Factor | Treatment | No treatment | Crude OR | Adjusted OR |
All | 142 (56) | 112 (44) | ||
Index factors | ||||
Sex | ||||
Males | 89 (54) | 75 (46) | 1 | 1 |
Females | 53 (59) | 37 (41) | 1.1 (0.5–2.1) | 1.1 (0.5–2.6) |
Age | ||||
0–14 years | 1 (33) | 2 (67) | 0.8 (0.3–1.8) | 0.1 (0.1–0.7) |
15–34 years | 98 (62) | 59 (38) | 3.3 (1.3–8.4) | 1.8 (0.5–6.0) |
35–54 years | 30 (50) | 30 (50) | 1.7 (0.6–4.6) | 1.0 (0.2–3.8) |
≥55 years | 13 (38) | 21 (62) | 1 | 1 |
Country of birth | ||||
The Netherlands | 43 (57) | 33 (43) | 1 | |
Outside the Netherlands | 99 (56) | 79 (44) | 1.0 (0.5–2.0) | |
At risk# | ||||
No | 135 (56) | 107 (44) | 1 | |
Yes | 7 (58) | 5 (42) | 0.8 (0.2–3.6) | |
Sputum smear status | ||||
Positive | 139 (57) | 106 (43) | 1 | |
Negative | 3 (33) | 6 (67) | 0.3 (0.8–1.5) | |
Contact factors | ||||
Sex | ||||
Male | 89 (56) | 69 (44) | 1 | 1 |
Female | 53 (55) | 43 (45) | 0.8 (0.5–1.4) | 0.8 (0.5–1.4) |
Age | ||||
0–4 years | 8 (100) | 0 | ||
5–14 years | 16 (76) | 5 (24) | 10.5 (2.6–41.5)¶ | 8.5 (2.1–34.6) ¶ |
15–34 years | 57 (65) | 31 (35) | 4.1 (1.3–12.7) | 4.0 (1.3–12.4) |
35–54 years | 48 (52) | 45 (48) | 2.4 (1.0–5.8) | 2.3 (0.8–5.9) |
≥55 years | 13 (29) | 31 (71) | 1 | 1 |
Nationality | ||||
Dutch | 98 (64) | 55 (36) | 1.7 (0.8–3.6) | 2.6 (1.2–5.4) |
Other | 40 (51) | 38 (49) | 1 | 1 |
Unknown | 4 (17) | 19 (83) | 0.2 (0.1–0.5) | 0.4 (0.1–1.1) |
Type of contact | ||||
First circle | 99 (63) | 59 (37) | 10.6 (1.7–63.2) | 10.5 (1.5–70.7) |
Second circle | 39 (49) | 40 (51) | 5.3 (0.8–34.7) | 5.3 (0.7–37.1) |
Third circle | 2 (18) | 9 (82) | 1 | 1 |
Unknown | 2 (33) | 4 (67) | 2.8 (0.4–16.7) | 1.5 (0.2–11.8) |
BCG | ||||
No evidence of vaccination/unknown | 89 (58) | 65 (42) | 1 | |
Evidence of vaccination | 53 (53) | 47 (47) | 0.7 (0.4–1.3) |
Data are presented as n (%) or OR (95% CI). BCG: bacille Calmette–Guérin. #: the homeless and drug users; ¶: age categories 0–4 and 5–14 years were combined to calculate the odds ratio.